Covered recipient · General Payments record
ROANNA MICHELLE EGGERT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,800.94
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $597.56 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $248.61 | 5 |
| Acerta Pharma LLC | $125.00 | 1 |
| Insulet Corporation | $64.48 | 3 |
| Abbott Laboratories | $45.44 | 2 |
| Novo Nordisk AS | $41.00 | 2 |
| Exact Sciences Corporation | $36.57 | 2 |
| Phadia US Inc. | $18.94 | 1 |
| DEXCOM, INC. | $17.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.85 | 02/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312880 | CMS |
| Abbott Laboratories | $20.59 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125312882 | CMS |
| ABBVIE INC. | $22.74 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107063676 | CMS |
| ABBVIE INC. | $20.60 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107063678 | CMS |
| ABBVIE INC. | $106.15 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107063680 | CMS |
| ABBVIE INC. | $82.62 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107063682 | CMS |
| ABBVIE INC. | $16.50 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107063684 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104251615 | CMS |
| Dexcom, Inc. | $17.52 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153383786 | CMS |
| Exact Sciences Corporation | $18.35 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114532707 | CMS |
| Exact Sciences Corporation | $18.22 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114532711 | CMS |
| Insulet Corporation | $21.57 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116795903 | CMS |
| Insulet Corporation | $23.59 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116800496 | CMS |
| Insulet Corporation | $19.32 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116800492 | CMS |
| Novo Nordisk Inc | $24.92 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100416902 | CMS |
| Novo Nordisk Inc | $16.08 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100628508 | CMS |
| Phadia US Inc. | $18.94 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067585460 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.